Induction of morphological changes in human embryo liver cells by the pyrrolizidine alkaloid lasiocarpine.
D000470:Alkaloids / Q000633:toxicity*; D000478:Alkylation; D002462:Cell Membrane / Q000187:drug effects; D002466:Cell Nucleolus / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D002875:Chromosomes / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D006571:Heterocyclic Compounds / Q000633:toxicity*; D006801:Humans; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects; D008938:Mitosis / Q000187:drug effects; D009154:Mutation / Q000187:drug effects; D014176:Protein Biosynthesis; D011763:Pyrrolizidine Alkaloids / Q000633:toxicity; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000470:Alkaloids; D006571:Heterocyclic Compounds; D011763:Pyrrolizidine Alkaloids; D014316:Tritium; D004247:DNA; D007930:Leucine; D013936:Thymidine; D014529:Uridine